CCR6 and pulmonary emphysema: In murine models, CCR6 deficiency or IL-23 blockade reduced cigarette smoke–induced emphysema, whereas anti-IL-23 treatment in severe asthma patients worsened outcomes, highlighting the complex role of the Th17 axis in airway disease (36, 37).